Therefore, other observations are strongly required to assess the role of BAP1 on mesothelioma biology and with particular attention to drugs used for this cancer such as pemetrexed and platinum-based treatments, as well as to avoid second line treatment with compounds not effective in BAP1 mutant patients [48]. The gene discussed is BAP1; the disease is mesothelioma.